Skip to main content

Correction to: The value of co-creating a clinical outcome assessment strategy for clinical trial research: process and lessons learnt

The Original Article was published on 24 October 2023


Correction to: Research Involvement and Engagement (2023) 9:98 https://0-doi-org.brum.beds.ac.uk/10.1186/s40900-023-00505-7

Following publication of the original article [1], the authors reported errors in reference 13. The revised link in reference 13 has been indicated hereafter.


The incorrect reference 13 reads:


13. FDA. Assessment of the use of patient experience data in regulatory decision-making final report. https://www.fda.gov/drugs/development-approval-process-drugs/fda-patient-focused-drug-development-guidance-series-enhancing-incorporation-patients-voice-medical. Accessed 06 Mar 2023.


The correct reference 13 should read:


13. FDA. Assessment of the use of patient experience data in regulatory decision-making final report. https://www.fda.gov/drugs/development-approval-process-drugs/assessment-use-patient-experience-data-regulatory-decision-making Accessed 06 Mar 2023.


All the changes requested are implemented in this correction and the original article [1] has been corrected.

Reference

  1. Morel T, Schroeder K, Cleanthous S, et al. The value of co-creating a clinical outcome assessment strategy for clinical trial research: process and lessons learnt. Res Involv Engagem. 2023;9:98. https://0-doi-org.brum.beds.ac.uk/10.1186/s40900-023-00505-7.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Thomas Morel.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Morel, T., Schroeder, K., Cleanthous, S. et al. Correction to: The value of co-creating a clinical outcome assessment strategy for clinical trial research: process and lessons learnt. Res Involv Engagem 10, 5 (2024). https://0-doi-org.brum.beds.ac.uk/10.1186/s40900-023-00538-y

Download citation

  • Published:

  • DOI: https://0-doi-org.brum.beds.ac.uk/10.1186/s40900-023-00538-y